Page 66 - Biomarkers for risk stratification and guidance in heart failure
P. 66
EDITORIAL
Biomarker-Guided Treatment of Heart Failure Still Waiting for a Definitive Answer
Richard W. Troughton, MB CHB, PHD, Chris M. Frampton, PHD, M. Gary Nicholls, MD Christchurch, New Zealand
From the Christchurch Cardioendocrine Research Group and the University of Otago, Christchurch, New Zealand.
